ING Groep NV decreased its position in Danaher Corporation (NYSE:DHR – Free Report) by 51.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 169,604 shares of the conglomerate’s stock after selling 181,382 shares during the period. ING Groep NV’s holdings in Danaher were worth $38,826,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Elevated Capital Advisors LLC bought a new position in Danaher in the fourth quarter valued at about $26,000. JPL Wealth Management LLC acquired a new position in Danaher in the third quarter valued at about $25,000. WFA of San Diego LLC acquired a new position in Danaher in the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher in the third quarter valued at about $27,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in Danaher in the fourth quarter valued at about $33,000. Institutional investors own 79.05% of the company’s stock.
Analysts Set New Price Targets
Several research firms have weighed in on DHR. Evercore increased their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Wells Fargo & Company cut their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Barclays cut their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Robert W. Baird cut their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $235.14.
Danaher Stock Down 1.2%
DHR stock opened at $184.45 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market capitalization of $130.55 billion, a P/E ratio of 35.68, a P/E/G ratio of 2.46 and a beta of 0.81. The business has a 50-day moving average of $181.29 and a 200-day moving average of $206.19. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.88 earnings per share. On average, sell-side analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.
Danaher Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
